Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
SQ
|
Roelof Botha
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 19.63% |
-
|
Jun 16
2020 |
SQ
|
Paul Deighton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 4.99% |
-
|
Jun 16
2020 |
SQ
|
Randall J Garutti
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 12.42% |
-
|
Jun 16
2020 |
SQ
|
Mary G Meeker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 0.66% |
-
|
Jun 16
2020 |
SQ
|
Anna Patterson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 14.54% |
-
|
Jun 16
2020 |
SQ
|
Lawrence Henry Summers
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 11.37% |
-
|
Jun 16
2020 |
SQ
|
David A Viniar
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,376 Added 4.52% |
-
|
Jun 16
2020 |
SQ
|
Darren Walker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 50.0% |
-
|
Jun 16
2020 |
SQ
|
James Morgan Mc Kelvey Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,638 Added 3.22% |
-
|
Jun 16
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 39,752 Reduced 100.0% |
$2,581,495
$64.94 p/Share
|
Jun 16
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 39,752 Added 50.0% |
$761,251
$19.15 p/Share
|
Jun 16
2020 |
TMP
|
Ita M Rahily
Director |
BUY
Open market or private purchase
|
Direct | 40 Added 3.28% |
$2,481
$62.02 p/Share
|
Jun 16
2020 |
CNS
|
Matthew S. Stadler
Chief Financial Officer, EVP |
SELL
Open market or private sale
|
Direct | 18,219 Reduced 12.52% |
$1,312,315
$72.03 p/Share
|
Jun 16
2020 |
GBIO
|
Zone Healthcare Holdings, LLC |
BUY
Open market or private purchase
|
Direct | 400,000 Added 17.25% |
$7,600,000
$19.0 p/Share
|
Jun 16
2020 |
GBIO
|
Zone Healthcare Holdings, LLC |
BUY
Conversion of derivative security
|
Direct | 1,518,819 Added 50.0% |
-
|
Jun 16
2020 |
PGC
|
Beth Welsh |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 27.41% |
$36,700
$14.68 p/Share
|
Jun 16
2020 |
PGC
|
Beth Welsh |
SELL
Payment of exercise price or tax liability
|
Direct | 1,896 Reduced 31.51% |
$36,688
$19.35 p/Share
|
Jun 16
2020 |
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
SELL
Open market or private sale
|
Direct | 256,181 Reduced 40.8% |
$8,351,500
$32.6 p/Share
|
Jun 16
2020 |
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 256,181 Added 28.98% |
$4,549,775
$17.76 p/Share
|
Jun 16
2020 |
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 236 Added 0.09% |
$151,359
$641.35 p/Share
|
Jun 16
2020 |
ADBE
|
Amy Banse
Director |
SELL
Open market or private sale
|
Direct | 5,100 Reduced 14.27% |
$2,096,151
$411.01 p/Share
|
Jun 16
2020 |
ADBE
|
Dana Rao
EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 2,025 Reduced 10.53% |
$833,510
$411.61 p/Share
|
Jun 16
2020 |
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Indirect | 12,500 Reduced 2.83% |
$5,134,375
$410.75 p/Share
|
Jun 16
2020 |
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 212,337 Reduced 0.19% |
$34,604,561
$162.97 p/Share
|
Jun 16
2020 |
MDIA
|
Ryan A Hornaday
EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 474 Reduced 3.85% |
$3,209
$6.77 p/Share
|
Jun 16
2020 |
AMPY
|
Brigade Capital Management, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 21,911 Reduced 0.29% |
$39,878
$1.82 p/Share
|
Jun 16
2020 |
CNA
|
Loews Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 37,567 Added 0.02% |
$1,216,044
$32.37 p/Share
|
Jun 16
2020 |
GRTX
|
Novartis Bioventures LTD |
SELL
Open market or private sale
|
Direct | 8,600 Reduced 0.25% |
$79,980
$9.3 p/Share
|
Jun 16
2020 |
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 0.11% |
$200,550
$5.73 p/Share
|
Jun 16
2020 |
ARES
|
Antony P Ressler
Co-Founder & Exec. Chairman |
SELL
Open market or private sale
|
Indirect | 94,512 Reduced 4.22% |
$3,713,377
$39.29 p/Share
|
Jun 16
2020 |
GBIO
|
James E Flynn
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 225,000 Added 15.94% |
$4,275,000
$19.0 p/Share
|
Jun 16
2020 |
GBIO
|
James E Flynn
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 961,215 Added 35.58% |
-
|
Jun 16
2020 |
RNA
|
Rtw Investments, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 950,000 Added 19.21% |
$17,100,000
$18.0 p/Share
|
Jun 16
2020 |
RNA
|
Rtw Investments, LP
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 3,045,000 Added 50.0% |
-
|
Jun 16
2020 |
RNA
|
Lilly & CO Eli |
BUY
Conversion of derivative security
|
Direct | 2,169,396 Added 50.0% |
-
|
Jun 16
2020 |
PCVX
|
Patrick J Heron
Director |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 9.77% |
$4,000,000
$16.0 p/Share
|
Jun 16
2020 |
PCVX
|
Patrick J Heron
Director |
BUY
Conversion of derivative security
|
Indirect | 2,059,554 Added 22.32% |
-
|
Jun 16
2020 |
PCVX
|
Robert Lorne Hopfner
Director |
BUY
Open market or private purchase
|
Indirect | 93,000 Added 4.02% |
$1,488,000
$16.0 p/Share
|
Jun 16
2020 |
PCVX
|
Robert Lorne Hopfner
Director |
BUY
Conversion of derivative security
|
Indirect | 2,129,967 Added 23.19% |
-
|
Jun 16
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 7.7% |
$905,250
$181.05 p/Share
|
Jun 16
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 7.15% |
$296,700
$59.34 p/Share
|
Jun 16
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
SELL
Bona fide gift
|
Indirect | 500 Reduced 0.05% |
-
|
Jun 16
2020 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$2,712,150
$180.81 p/Share
|
Jun 16
2020 |
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Jun 16
2020 |
IBCP
|
Christina Keller
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 13.07% |
$15,090
$15.09 p/Share
|
Jun 16
2020 |
AUB
|
Michael W Clarke |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.39% |
$47,680
$23.84 p/Share
|
Jun 16
2020 |
UBER
|
Robert Eckert |
BUY
Open market or private purchase
|
Indirect | 15,740 Added 0.0% |
$497,384
$31.6 p/Share
|
Jun 15
2020 |
LTRN
|
Aaron G.L. Fletcher
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,456,648 Added 0.0% |
-
|
Jun 15
2020 |
REGN
|
Christopher R. Fenimore
VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 3,670 Reduced 18.06% |
$2,157,593
$587.9 p/Share
|
Jun 15
2020 |
REGN
|
Christopher R. Fenimore
VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 9,406 Added 33.31% |
$388,749
$41.33 p/Share
|
Jun 15
2020 |